Access cutting-edge alpha-1 antitrypsin deficiency treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.
Access alpha-1 antitrypsin deficiency specialists in Miami at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alpha-1 antitrypsin deficiency treatment provided free
The liver produces a protein called alpha-1 antitrypsin (AAT). AAT is normally released into the bloodstream. In some people, the liver makes an abnormal version of the AAT protein, called Z-AAT. Making an abnormal version of the AAT protein can result in liver disease as Z-AAT builds up in liver cells, which leads to liver problems such as liver scarring (fibrosis), continuing liver damage (cirrhosis), and eventually end stage liver disease. Fazirsiran is a medicine that reduces the creation of
Sponsor: Takeda
Check if you qualify for this alpha-1 antitrypsin deficiency clinical trial in Miami, FL
If you're searching for alpha-1 antitrypsin deficiency treatment options in Miami, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alpha-1 antitrypsin deficiency specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.